ATE297717T1 - Heparin und diclofenac enthaltendes topisches pflaster - Google Patents

Heparin und diclofenac enthaltendes topisches pflaster

Info

Publication number
ATE297717T1
ATE297717T1 AT00107835T AT00107835T ATE297717T1 AT E297717 T1 ATE297717 T1 AT E297717T1 AT 00107835 T AT00107835 T AT 00107835T AT 00107835 T AT00107835 T AT 00107835T AT E297717 T1 ATE297717 T1 AT E297717T1
Authority
AT
Austria
Prior art keywords
diclofenac
patch containing
containing heparin
topical patch
heparin
Prior art date
Application number
AT00107835T
Other languages
English (en)
Inventor
Elisabetta Donati
Irina Rapaport
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Sa filed Critical Altergon Sa
Application granted granted Critical
Publication of ATE297717T1 publication Critical patent/ATE297717T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00107835T 1999-04-21 2000-04-12 Heparin und diclofenac enthaltendes topisches pflaster ATE297717T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000834A IT1312088B1 (it) 1999-04-21 1999-04-21 Cerotto per uso topico contenente eparina e diclofenac.

Publications (1)

Publication Number Publication Date
ATE297717T1 true ATE297717T1 (de) 2005-07-15

Family

ID=11382783

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00107835T ATE297717T1 (de) 1999-04-21 2000-04-12 Heparin und diclofenac enthaltendes topisches pflaster

Country Status (9)

Country Link
US (3) US6592891B1 (de)
EP (1) EP1046395B1 (de)
AT (1) ATE297717T1 (de)
CA (1) CA2306214C (de)
DE (1) DE60020768T2 (de)
DK (1) DK1046395T3 (de)
ES (1) ES2244373T3 (de)
IT (1) IT1312088B1 (de)
PT (1) PT1046395E (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0215068A (pt) 2001-12-21 2004-11-09 Coloplast As Dispositivo para cuidar de feridas
JP2004168764A (ja) * 2002-10-30 2004-06-17 Showa Denko Kk 貼付剤用粘着剤組成物およびその製造方法
WO2004039358A1 (en) * 2002-10-30 2004-05-13 Showa Denko K.K. Adhesive composition for dermal patch and production process thereof
US8529939B2 (en) * 2003-12-08 2013-09-10 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
WO2006025583A1 (ja) * 2004-08-31 2006-03-09 Aspion Co., Ltd. Ｓ／ｏ型外用剤
WO2006112533A1 (en) * 2005-04-18 2006-10-26 Showa Denko K.K. Water-containing gel form and production method thereof
US20100323323A1 (en) * 2005-06-24 2010-12-23 Cao Group, Inc. Pliable gingival isolation material
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
ES2472545T3 (es) 2006-07-25 2014-07-01 Techfields Biochem Co. Ltd Profármacos de diclofenaco solubles en agua con carga positiva y con una tasa de penetración en piel muy rápida
US9371284B2 (en) 2007-06-04 2016-06-21 Techfields Pharma Co., Ltd. Pro-drugs of NSAIAS with very high skin and membranes penetration rates and their new medicinal uses
DK2259781T3 (da) * 2008-03-03 2014-08-11 Altergon Sa Fremgangsmåde til fremstilling af et farmaceutisk præparat med antiinflammatorisk og analgetisk aktivitet til administration via et plaster til udvortes brug, og således opnået præparat
CN104173321B (zh) * 2008-03-03 2017-10-31 阿尔特根有限公司 制备通过外用贴剂给药的、具有消炎镇痛活性的药物组合物的方法，及以此获得的组合物
US7943668B2 (en) 2008-03-03 2011-05-17 Altergon S.A. Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained
KR20230085223A (ko) 2008-12-04 2023-06-13 충시 위 고투과력을 가진 조성물 및 이의 적용
CN103357059B (zh) * 2012-03-27 2016-08-03 上海卫生材料厂有限公司 几丁质凝胶创可贴
US10905669B2 (en) 2015-02-20 2021-02-02 Altergon S.A. Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
EP3173066A1 (de) * 2015-11-25 2017-05-31 Krzysztof Kubica Pflaster mit antiödematösen substanzen zur behandlung von prellung und verletzung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855142A (en) * 1987-02-27 1989-08-08 Ciba-Geigy Corporation Pharmaceutical plaster
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
US5217954A (en) * 1990-04-04 1993-06-08 Scios Nova Inc. Formulations for stabilizing fibroblast growth factor
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
JP3526887B2 (ja) * 1993-04-23 2004-05-17 帝國製薬株式会社 消炎鎮痛外用貼付剤
US5668119A (en) * 1996-02-22 1997-09-16 Medenica; Rajko D. Topical pharmaceutical containing heparin and method of treatment
AU2953497A (en) * 1996-05-13 1997-12-05 Novartis Consumer Health S.A. Topical composition
GB2320431B (en) * 1996-12-20 2000-08-30 Johnson & Johnson Medical Compositions for the treatment of chronic wounds

Also Published As

Publication number Publication date
PT1046395E (pt) 2005-10-31
US20030203017A1 (en) 2003-10-30
DE60020768T2 (de) 2006-05-18
DK1046395T3 (da) 2005-10-03
EP1046395B1 (de) 2005-06-15
US7799338B2 (en) 2010-09-21
ITMI990834A1 (it) 2000-10-21
US20050048101A1 (en) 2005-03-03
CA2306214C (en) 2009-10-20
EP1046395A1 (de) 2000-10-25
US6592891B1 (en) 2003-07-15
CA2306214A1 (en) 2000-10-21
ES2244373T3 (es) 2005-12-16
IT1312088B1 (it) 2002-04-04
DE60020768D1 (de) 2005-07-21

Similar Documents

Publication Publication Date Title
ATE297717T1 (de) Heparin und diclofenac enthaltendes topisches pflaster
ES2581574T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
WO2004103415A3 (en) Multi-dressing system for managing skin wounds
WO2007044647A3 (en) Pressure bandage with medication delivery system
AU2003247616A1 (en) Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis
DE602005016185D1 (de) Druckempfindliche Klebstoffzusammensetzung, druckempfindliches Klebeband und Oberflächenschutzfilm
DK1009393T3 (da) Transdermalt, terapeutisk system med hæfteklæbende reservoirlag og bagsidelag, som er elastisk i én retning
JP2005502430A5 (de)
MY119660A (en) D2-agonist-containing transdermal therapeutic system for the treatment of parkinsons syndrome and a process for its production.
ES2188907T3 (es) Dispositivo de soporte farmaceutico adecuado ppara la administracion de compuestos farmaceuticos a las superficies de las mucosas.
HUP0103715A2 (hu) Topikus tapasz savcsoportot tartalmazó nemszteroid reumaellenes hatóanyaggal
NO20050472L (no) Forbedret transdermalt leveringssystem for administrering av rotigotin
WO2005007020A3 (en) Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
WO2003018075A3 (de) Transdermales therapeutisches system mit fentanyl bzw. verwandten substanzen
MX2009005343A (es) Sistema terapeutico transdermico con alto grado de utilizacion de sustancia activa y precision de dosificacion.
AR043248A1 (es) Sistema terapeutico transdermico estable a los rayos uv
EA201300704A1 (ru) Трансдермальная терапевтическая система для введения активного вещества
TW200501939A (en) Patch containing nonsteroidal anti-inflammatory and analgesic agent
WO2005067499A3 (en) Method and device for topical delivery of therapeutic agents to the skin
DK1355636T3 (da) Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf
AU2003230032A1 (en) Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
AU2003234936A1 (en) Liquid crystal aligning agent, liquid crystal aligning films and liquid crystal display devices
CA2387143A1 (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
AU2003241564A1 (en) Thin film scar dressing and use thereof
MX2009008993A (es) Dispositivo para la administracion percutanea de bisoprolol.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1046395

Country of ref document: EP